FDA Issues Alert for Medical Devices Providing Incorrect Glucose Readings, Causing 7 Deaths

The U.S. Food and Drug Administration has issued a recall of glucose monitors used by those with diabetes for malfunctioning.
MobiHealthNews

Canada approves Abbott’s FreeStyle Libre 2 for adults and children with diabetes

Abbott’s continuous glucose monitoring system, the FreeStyle Libre 2, has been approved in Canada for adults and children four years and older with diabetes. The FreeStyle Libre 2 system ...
HME News

Abbott issues correction for Freestyle Libre 3 and 3 Plus sensors

Abbott has initiated a medical device correction for certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors in the United States after internal testing determined that some ...
Nasdaq

Abbott's FreeStyle Libre® 2 Receives National Reimbursement in France for All People with Diabetes Who Use Insulin¹

ABBOTT PARK, Ill., June 22, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) today announced that the French health authority has approved the expansion of reimbursement coverage for its FreeStyle ...
MobiHealthNews

Abbott's FreeStyle Libre 2 CGM picks up Medicare coverage

Abbott announced yesterday that its recently cleared FreeStyle Libre 2 integrated continuous glucose monitoring (CGM) system is now covered by the Centers for Medicare and Medicaid Services ...